$IMNM insider trading

Over the last 12 months, Immunome insiders reported 1 buy totaling $204K and 8 sales totaling $12.7M across SEC Form 4 filings. 78% of the activity was filed under pre-arranged 10b5-1 trading plans.

$204K
$12.7M
9
5
78%
Side
$10K$100K$1.0M$10MJun '26JulAug
BIENAIME JEAN JACQUES
Horn Kinney
Lechleider Robert
Barchas Isaac
Rosett Max

All insider trades

Aug 4, 2026Horn Kinney▼ Sale90,616$25.09$2.3M-100%
Jul 7, 2026Horn Kinney▼ Sale1,092$25$27K-100%
Jul 7, 2026Barchas Isaac▼ Sale100,000$24.13$2.4M-48%
Jul 2, 2026Barchas Isaac▼ Sale201,050$21.85$4.4M-49.1%
Jul 2, 2026Lechleider Robert▼ Sale55,000$22.62$1.2M-77.7%
Jun 25, 2026Lechleider Robert▼ Sale55,000$19.85$1.1M-77.7%
Jun 15, 2026Rosett Max▼ Sale60,000$18.23$1.1M-52.6%
Jun 5, 2026BIENAIME JEAN JACQUES▲ Buy10,500$19.45$204K+31.9%
Jun 5, 2026BIENAIME JEAN JACQUES▼ Sale10,500$19.41$204K-24.2%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IMNM feed.

IMNM Insider Trading — Form 4 Buys & Sells | alphai